Comparison Chart Mirum Pharmaceuticals, Inc.

MIRM

US6047491013

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	MIRUM PHARMACEUTICALS, INC.	Other Pharmaceuticals	+0.29%	+2.84%	+8.63%	+21.70%	+446.21%	5.56B

10-26	Mirum Pharmaceuticals, Inc. Announces Positive Results From Cohort 2 Of The Pivotal PROGRESS Study Of ATEBRIOZ In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva	CI
10-26	Mirum Drug Shows Promise Against Abnormal Bone Growth in Pediatric Phase 2 Trial	MT

Market Closed - Nasdaq 16:00:00 2026-10-28 EDT			5-day change	1st Jan Change
85.81 ^USD	+0.29%		+2.84%	+8.63%

Comparison Chart Mirum Pharmaceuticals, Inc.

Stocks

MIRM

US6047491013

Pharmaceuticals

Compared values